EPRG EPR quarterly earnings release arrives management to outline fullyear strategic priorities on investor call Bristol Myers Squibb BMY Valuation Deep Dive Assessing If The LargeCap Pharma Name Is The Best Bargain In Big Pharma BNC CEA Indus shares climb 941 percent following the release of its Q3 2023 earnings results